CSIMarket


Oncocyte Corporation  (OCX)
Other Ticker:  
 

Oncocyte Corporation

OCX's Fundamental analysis








Looking into Oncocyte growth rates, revenue grew by 946.34 % in III. Quarter 2023 from the same quarter a year ago. Ranking at No. 1932

In Vitro & In Vivo Diagnostic Substances industry recorded growth of revenues by 11.11 %

Oncocyte net loss deacreased by in III. Quarter 2023 year on year, Oncocyte net loss increased by -30.02 % in III. Quarter 2023 year on year,

More on OCX's Growth


Oncocyte
realized net loss in trailing twelve months.

Oncocyte realized cash outflow of $ -0per share in trailing twelve-month period.
In Vitro & In Vivo Diagnostic Substances industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 4148.18.
In Vitro & In Vivo Diagnostic Substances industry's Price to Sales ratio is at 10.89.


More on OCX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 3.16
 Tangible Book Value (Per Share $) 0.00

Oncocyte
realized net loss in trailing twelve months.

Oncocyte realized cash outflow of $ -0per share in trailing twelve-month period.
In Vitro & In Vivo Diagnostic Substances industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 4148.18.
In Vitro & In Vivo Diagnostic Substances industry's Price to Sales ratio is at 10.89.

Oncocyte Price to Book Ratio is at 654.99 higher than Indusry Avg. of 541.99, and higher than S&P 500 Avg. of -1999.75

More on OCX's Valuation

  Market Capitalization (Millions $) 24,603
  Shares Outstanding (Millions) 8,256
  Employees -
  Revenues (TTM) (Millions $) 6
  Net Income (TTM) (Millions $) -77
  Cash Flow (TTM) (Millions $) -18
  Capital Exp. (TTM) (Millions $) -1
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 3.16
  Tangible Book Value (Per Share $) 0.00

  Market Capitalization (Millions $) 24,603
  Shares Outstanding (Millions) 8,256
  Employees -
  Revenues (TTM) (Millions $) 6
  Net Income (TTM) (Millions $) -77
  Cash Flow (TTM) (Millions $) -18
  Capital Exp. (TTM) (Millions $) -1





  Ratio
   Capital Ratio (MRQ) 2.11
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.07
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com